QSS
ENTA icon

Quantitative Systematic Strategies’s Enanta Pharmaceuticals ENTA Stock Holding History

Quantitative Systematic Strategies’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,501
Closed -$226K – 633
2020
Q2 		$226K Buy
+4,501
New +$233K 0.04% 487

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Quantitative Systematic Strategies's ENTA Position: Q3 2020 in Review

Quantitative Systematic Strategies sold out of Enanta Pharmaceuticals (ENTA) in Q3 2020, closing a stake of 4,501 shares — an estimated $226K sold.

Quantitative Systematic Strategies first reported a position in ENTA in Q2 2020 and held it in 1 quarter. The position peaked at $226K in Q2 2020. 172 funds tracked by Wall St. Rank hold ENTA as of Q3 2020.

  • Quantitative Systematic Strategies reported no remaining Enanta Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 4,501 Enanta Pharmaceuticals shares in Q3 2020, an estimated $226K.
  • Quantitative Systematic Strategies first reported a position in Enanta Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Enanta Pharmaceuticals position peaked at $226K in Q2 2020.
  • 172 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2020, filed 9 Nov 2020.